Interobserver agreement of interim and end-of-treatment 18F-FDG PET/CT in diffuse large B-cell lymphoma: impact on clinical practice and trials
CN Burggraaff, AC Cornelisse… - Journal of Nuclear …, 2018 - Soc Nuclear Med
We aimed to assess the interobserver agreement of interim PET (I-PET) and end-of-
treatment PET (EoT-PET) using the Deauville score (DS) in first-line diffuse large B-cell …
treatment PET (EoT-PET) using the Deauville score (DS) in first-line diffuse large B-cell …
[HTML][HTML] The optimal timing of interim 18F-FDG PET in diffuse large B-cell lymphoma: An individual patient data meta-analysis by the Petra consortium
Introduction Diffuse large B-Cell lymphoma (DLBCL) is the most common subtype of non-
Hodgkin lymphoma (NHL). Up to one third of patients relapse or fail to achieve complete …
Hodgkin lymphoma (NHL). Up to one third of patients relapse or fail to achieve complete …
18F-FDG PET/CT for early response assessment in diffuse large B-cell lymphoma: poor predictive value of international harmonization project interpretation
AF Cashen, F Dehdashti, J Luo, A Homb… - Journal of Nuclear …, 2011 - Soc Nuclear Med
PET using 18F-FDG has prognostic value when performed at the completion of initial
chemotherapy in patients with diffuse large B-cell lymphoma (DLBCL). 18F-FDG PET may …
chemotherapy in patients with diffuse large B-cell lymphoma (DLBCL). 18F-FDG PET may …
An international confirmatory study of the prognostic value of early PET/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and ΔSUVmax
E Itti, M Meignan, A Berriolo-Riedinger, A Biggi… - European journal of …, 2013 - Springer
Purpose The role of interim PET/CT in guiding therapeutic strategies in diffuse large B-cell
lymphoma (DLBCL) is debated, mainly because interpretation rules vary among centres …
lymphoma (DLBCL) is debated, mainly because interpretation rules vary among centres …
Combined visual and semiquantitative evaluation improves outcome prediction by early midtreatment 18F-FDG PET in diffuse large B-cell lymphoma
T Györke, R Carr, JJ Cerci, C Meneghetti… - Journal of Nuclear …, 2020 - Soc Nuclear Med
The purpose of this study was to assess the predictive and prognostic value of interim FDG
PET (iPET) in evaluating early response to immunochemotherapy after 2 cycles (PET-2) in …
PET (iPET) in evaluating early response to immunochemotherapy after 2 cycles (PET-2) in …
Interim PET-driven strategy in de novo diffuse large B-cell lymphoma: do we trust the driver?
S Le Gouill, RO Casasnovas - Blood, The Journal of the …, 2017 - ashpublications.org
Abstract 18F-Fluorodeoxyglucose–positron emission tomography (FDG-PET) has become a
central tool for both accurate initial staging and determination of prognosis after treatment of …
central tool for both accurate initial staging and determination of prognosis after treatment of …
[HTML][HTML] Use of subsequent PET/CT in diffuse large B-cell lymphoma patients in complete remission following primary therapy
X Zhang, W Fan, ZJ Xia, YY Hu, XP Lin… - Chinese journal of …, 2015 - Springer
Abstract Interim 18 F-fluorodeoxyglucose (FDG) positron emission tomography/computed
tomography (I-PET/CT) is a powerful tool for monitoring the response to therapy in diffuse …
tomography (I-PET/CT) is a powerful tool for monitoring the response to therapy in diffuse …
Optimal timing and criteria of interim PET in DLBCL: a comparative study of 1692 patients
JJ Eertink, CN Burggraaff, MW Heymans… - Blood …, 2021 - ashpublications.org
Interim 18F-fluorodeoxyglucose positron emission tomography (Interim-18F-FDG-PET,
hereafter I-PET) has the potential to guide treatment of patients with diffuse large B-cell …
hereafter I-PET) has the potential to guide treatment of patients with diffuse large B-cell …
Utility of interim and end-of-treatment [18F]-fluorodeoxyglucose positron emission tomography–computed tomography in frontline therapy of patients with diffuse large …
SF Huntington, SD Nasta, SJ Schuster… - Leukemia & …, 2015 - Taylor & Francis
[18F]-fluorodeoxyglucose positron emission tomography–computed tomography (PET/CT) is
part of standard pretreatment staging and post-treatment assessment in patients undergoing …
part of standard pretreatment staging and post-treatment assessment in patients undergoing …
Predictive value of interim 18F-FDG-PET/CT for event-free survival in patients with diffuse large B-cell lymphoma homogenously treated in a phase II trial with six …
Objective The predictive value of interim PET/computed tomography (I-PET/CT) in diffuse
large B-cell lymphoma (DLBCL) is controversial. Our aim was to evaluate the predictive …
large B-cell lymphoma (DLBCL) is controversial. Our aim was to evaluate the predictive …